英文名稱 |
中文名稱 |
CAS號 |
操作 |
Desoximetasone Impurity 17 |
地塞米松甲磺酸鈉 |
3936-02-5 |
詳細(xì)
|
Dexamethasone Impurity G |
地塞米松磷酸鈉EP雜質(zhì)G(地塞米松酸) |
1597-78-0 |
詳細(xì)
|
Desoximetasone Impurity E |
醋酸地塞米松EP雜質(zhì)E |
1524-94-3 |
詳細(xì)
|
Desoximetasone Impurity |
地塞米松生物素 |
85679-56-7 |
詳細(xì)
|
Desoximetasone Impurity C |
醋酸地塞米松EP雜質(zhì)C |
|
詳細(xì)
|
Desoximetasone Impurity B |
醋酸地塞米松EP雜質(zhì)B |
|
詳細(xì)
|
Desoximetasone Impurity |
地塞米松17-甲酰氧基-17-酸 |
473273-04-0 |
詳細(xì)
|
Desoximetasone Impurity |
6-羥基地塞米松(非對映異構(gòu)體混合物) |
82778-08-3 |
詳細(xì)
|
Desmethyl Erlotinib Carboxylate Acid |
厄洛替尼雜質(zhì) |
1170354-84-3 |
詳細(xì)
|
Darunavir-O-Glucuronide |
達(dá)魯那韋雜質(zhì) |
1159613-27-0 |
詳細(xì)
|
D-Darunavir |
地瑞那韋雜質(zhì) |
1399859-60-9 |
詳細(xì)
|
Darunavir Impurity 9 |
達(dá)魯那韋雜質(zhì)8(R,R-異構(gòu)體) |
866594-61-8 |
詳細(xì)
|
Darunavir-d9 |
地瑞那韋雜質(zhì) |
1133378-37-6 |
詳細(xì)
|
Darunavir-N-Glucuronide |
達(dá)魯那韋雜質(zhì) |
1159613-25-8 |
詳細(xì)
|
Erlotinib Impurity 11 |
厄洛替尼雜質(zhì)11 |
950596-59-5 |
詳細(xì)
|
Erlotinib Impurity 11 |
厄洛替尼代謝產(chǎn)物M11 |
882172-60-3 |
詳細(xì)
|
Erlotinib Impurity 1 |
厄洛替尼雜質(zhì)1 |
2204518-92-1 |
詳細(xì)
|
Erlotinib Impurity 29 |
厄洛替尼雜質(zhì)29 |
574738-66-2 |
詳細(xì)
|
Erlotinib Impurity 1 |
厄洛替尼雜質(zhì) |
882420-22-6 |
詳細(xì)
|
Febuxostat Impurity 27;3-cyano-4-isobutoxybenzamide |
非布索坦雜質(zhì)27 |
|
詳細(xì)
|
Erlotinib Impurity 26 |
厄洛替尼雜質(zhì)26 |
3943-89-3 |
詳細(xì)
|
Febuxostat Impurity 26;3-cyano-4-isobutoxybenzoic acid |
非布索坦雜質(zhì)26 |
1886961-39-2 |
詳細(xì)
|
Valsartan Methyl Ester |
非布索坦雜質(zhì)48 |
2375033-35-3 |
詳細(xì)
|
Febuxostat Impurity 46 |
非布司他雜質(zhì)46 |
528607-60-5 |
詳細(xì)
|
Erlotinib O-Desmethyl Metabolite Isomer (M13) HCl |
厄洛替尼雜質(zhì) |
183365-34-6 |
詳細(xì)
|
Febuxostat Impurity 42 |
非布司他雜質(zhì)42 |
100118-38-5 |
詳細(xì)
|
Febuxostat Impurity 45 |
非布司他雜質(zhì)45 |
1229019-33-3 |
詳細(xì)
|
Erlotinib Impurity 35 |
厄洛替尼雜質(zhì)35 |
1839513-98-2 |
詳細(xì)
|
Erlotinib Impurity |
厄洛替尼O-去甲基代謝物異構(gòu)體(M14)HCl |
183320-51-6 |
詳細(xì)
|
Erlotinib Impurity 45 |
厄洛替尼雜質(zhì)45 |
183321-83-7 |
詳細(xì)
|
Erlotinib Impurity 71 |
厄洛替尼雜質(zhì)9 |
2055840-54-3 |
詳細(xì)
|
Febuxostat Impurity 41;4-hydroxybenzothioamide |
非布索坦雜質(zhì)41 |
|
詳細(xì)
|
Febuxostat Impurity 50;ethyl 2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)50 |
144060-84-4 |
詳細(xì)
|
Ezetimibe Impurity Q1;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((S)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one |
依折麥布雜質(zhì)Q1 |
|
詳細(xì)
|
Febuxostat Impurity 30;(Z)-ethyl 2-(3-((hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)30 |
|
詳細(xì)
|
Febuxostat Impurity 37 |
非布索坦雜質(zhì)46 |
2230270-05-8 |
詳細(xì)
|
Erlotinib Impurity 39 |
厄洛替尼雜質(zhì)39 |
|
詳細(xì)
|
DNV-II impurity 2 |
DNV-II雜質(zhì)2 |
1133153-38-4 |
詳細(xì)
|
Febuxostat Impurity 30 |
非布司他雜質(zhì)6 |
1271738-74-9 |
詳細(xì)
|
Febuxostat Impurity 44;ethyl 2-(3-formyl-2-hydroxyphenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)44 |
|
詳細(xì)
|
Desoximetasone Impurity |
地塞米松-17-酮(非對映異構(gòu)體混合物) |
2285-53-2 |
詳細(xì)
|
Febuxostat Impurity 52 |
非布司他雜質(zhì)52 |
18962-07-7 |
詳細(xì)
|
Cilnidipine Impurity 27 |
地屈孕酮 |
152-62-5 |
詳細(xì)
|
Febuxostat Impurity 53;isobutyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)53 |
1346238-13-8 |
詳細(xì)
|
Febuxostat Impurity 32;2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylic acid |
非布索坦雜質(zhì)32 |
1805770-41-5 |
詳細(xì)
|
Febuxostat Impurity 43;4-hydroxyisophthalonitrile |
非布索坦雜質(zhì)43 |
|
詳細(xì)
|
Febuxostat Impurity 47;2-(2-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid |
非布索坦雜質(zhì)47 |
|
詳細(xì)
|
D-Fudosteine |
福多司坦 |
1023971-10-9 |
詳細(xì)
|
Didesmethyl Erlotinib |
厄洛替尼雜質(zhì) |
183321-84-8 |
詳細(xì)
|
Erlotinib O-Desmethyl Metabolite Isomer (M13) |
厄洛替尼雜質(zhì) |
183320-29-8 |
詳細(xì)
|
Ezetimibe Impurity Q2;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((R)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one |
依折麥布雜質(zhì)Q2 |
|
詳細(xì)
|
Febuxostat Impurity 31;diethyl 2,2'-(4-hydroxy-5-(hydroxymethyl)-1,3-phenylene)bis(4-methylthiazole-5-carboxylate) |
非布索坦雜質(zhì)31 |
|
詳細(xì)
|
Febuxostat Impurity 82 |
非布索坦雜質(zhì)45 |
2230270-03-6 |
詳細(xì)
|
Febuxostat Impurity 36;2-(3-cyano-4-ethoxyphenyl)-4-methylthiazole-5-carboxylic acid |
非布索坦雜質(zhì)36 |
1805770-40-4 |
詳細(xì)
|
3, 4-dihydroxybenzaldehyde |
厄洛替尼雜質(zhì)68 |
139-85-5 |
詳細(xì)
|
Febuxostat Impurity 47 |
非布司他雜質(zhì)47 |
161718-85-0 |
詳細(xì)
|
Febuxostat Impurity 46 |
非布司他雜質(zhì)19 |
118485-48-6 |
詳細(xì)
|
Febuxostat Impurity 106 |
非布索坦雜質(zhì)54 |
1346238-15-0 |
詳細(xì)
|
Febuxostat Impurity 49;ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)49 |
|
詳細(xì)
|
Febuxostat Impurity 40;4-hydroxybenzonitrile |
非布索坦雜質(zhì)40 |
|
詳細(xì)
|
Darunavir Impurity A |
地瑞那韋雜質(zhì)A |
169280-56-2 |
詳細(xì)
|
Ezetimibe Impurity M |
依折麥布雜質(zhì)M |
|
詳細(xì)
|
Erlotinib-d6 HCl |
厄洛替尼雜質(zhì) |
1189953-78-3 |
詳細(xì)
|
Erlotinib Hydrochloride iMpurity 15 |
厄洛替尼雜質(zhì)15 |
|
詳細(xì)
|
(8S,9R,10S,11S,13S,14S,16R,17S) |
地塞米松EP雜質(zhì)F |
382-67-2 |
詳細(xì)
|
DNV-II impurity 1 |
DNV-II雜質(zhì)1 |
1005324-46-8 |
詳細(xì)
|
erythro-Hydroxy Bupropion HCl |
安非他酮雜質(zhì) |
80478-43-9 |
詳細(xì)
|
Captopril Impurity 1 |
卡托普利雜質(zhì)1 |
119238-52-7 |
詳細(xì)
|
Erlotinib iMpurity 41 |
厄洛替尼雜質(zhì)41 |
14235-81-5 |
詳細(xì)
|
Rosuvastatin EP Impurity A |
地屈孕酮雜質(zhì) |
25093-47-4 |
詳細(xì)
|
Erlotinib Impurity 30 |
厄洛替尼雜質(zhì)30 |
183322-16-9 |
詳細(xì)
|
(R)-Amlodipine |
醋酸地塞米松EP雜質(zhì)F |
2884-51-7 |
詳細(xì)
|
Pitavastatin Impurity 54 |
匹伐他汀雜質(zhì)54 |
1258947-30-6 |
詳細(xì)
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl) |
泊沙康唑?qū)τ钞悩?gòu)體 |
|
詳細(xì)
|
Erlotinib Impurity 46 |
厄洛替尼雜質(zhì)46 |
938185-06-9 |
詳細(xì)
|
(4aS,4bS,5aS,6aS,7R,8R,9aS,9bS) |
地塞米松EP雜質(zhì)D |
24916-90-3 |
詳細(xì)
|
Esomeprazole Impurity 25;2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-6-methoxy-1H-benzo[d]imidazole |
埃索美拉唑雜質(zhì)25 |
1080689-87-7 |
詳細(xì)
|
Erlotinib iMpurity 40 |
厄洛替尼雜質(zhì)40 |
|
詳細(xì)
|
Erlotinib Impurity 66 |
厄洛替尼雜質(zhì)66 |
1384975-87-4 |
詳細(xì)
|
Esomeprazole Impurity 22 |
埃索美拉唑雜質(zhì)22 |
|
詳細(xì)
|
Darunavir Impurity 7 (S,S-Isomer) |
達(dá)魯那韋雜質(zhì)7(S,S-異構(gòu)體) |
192800-79-6 |
詳細(xì)
|
Desoximetasone Impurity 16 |
地塞米松EP雜質(zhì)16 |
2265-64-7 |
詳細(xì)
|
DL-Folic Acid |
葉酸雜質(zhì)1 |
65165-92-6 |
詳細(xì)
|
Febuxostat Impurity 52 |
非布索坦雜質(zhì)52 |
|
詳細(xì)
|
D-Folic Acid |
葉酸雜質(zhì) |
65165-91-5 |
詳細(xì)
|
Erlotinib impurity 70 |
厄洛替尼雜質(zhì)67 |
1494468-76-6 |
詳細(xì)
|
(R)-Amlodipine |
非布司他雜質(zhì)25 |
2095166-41-7 |
詳細(xì)
|
Tacrolimus Diene |
去甲基他克莫司 |
132172-14-6 |
詳細(xì)
|
Febuxostat Impurity 88 |
非布索坦雜質(zhì)57 |
886501-78-6 |
詳細(xì)
|
Erlotinib Impurity 67 |
厄洛替尼雜質(zhì)44 |
183321-85-9 |
詳細(xì)
|
Erlotinib Hydrochloride iMpurity 14 |
厄洛替尼雜質(zhì)14 |
|
詳細(xì)
|
Dexamethasone Sodium Phosphate EP Impurity H |
地塞米松磷酸鈉EP雜質(zhì)H |
162968-22-1 |
詳細(xì)
|
Tacrolimus EP Impurity E |
他克莫司雜質(zhì) |
104987-30-6 |
詳細(xì)
|
Erlotinib Impurity 68 |
厄洛替尼雜質(zhì)A |
183321-82-6 |
詳細(xì)
|
Febuxostat iMpurity 20 |
非布索坦雜質(zhì)20 |
|
詳細(xì)
|
Esomeprazole Impurity 23 |
埃索美拉唑雜質(zhì)23 |
|
詳細(xì)
|
Noradrenaline Impurity 26 |
厄洛替尼 |
68304-21-3 |
詳細(xì)
|
Erlotinib Hydrochloride iMpurity 18 |
厄洛替尼雜質(zhì)18 |
|
詳細(xì)
|
Ezetimibe Impurity R |
依折麥布雜質(zhì)R |
|
詳細(xì)
|
Esomeprazole Impurity 24 |
埃索美拉唑雜質(zhì)24 |
|
詳細(xì)
|